News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
ASCO 2025 Science in Seconds: Charu Aggarwal on How a Molecular Assay May Help Identify People with NSCLC
Charu Aggarwal/pc3i.upenn.edu
Jun 1, 2025, 07:55

ASCO 2025 Science in Seconds: Charu Aggarwal on How a Molecular Assay May Help Identify People with NSCLC

American Society of Clinical Oncology (ASCO) shared a post on LinkedIn:

“Check out our ASCO 25 Science in Seconds!
Dr. Charu Aggarwal discusses how a molecular assay may help identify people with NSCLC who could benefit from adj. chemotherapy.
Learn more.”

Title: An international, multicenter, prospective randomized trial of adjuvant chemotherapy for stage Ia-IIa non-small cell lung cancer identified as high-risk by a 14-gene molecular assay

Journal: ASCO, Journal of Clinical Oncology

Authors: David Spigel, Virginie Westeel, Ian Anderson, Laurent Greillier, Florian Guisier, Olivier Bylicki, Firas Badin, Gaelle Rousseau-Bussac, Clotilde Deldycke, Frank Griesinger, Adam Bograd, Wangjian Zhong, Matthew Gubens, John Crowley, Heiko von der Leyen, Gavitt Woodard, Johannes Kratz, David Jablons, Michael Mann

Read the full abstract.

Charu Aggarwal

More posts featuring Charu Aggarwal on OncoDaily.

Adam Bograd American Society of Clinical Oncology ASCO ASCO 2025 Charu Aggarwal Clotilde Deldycke David Jablons David Spigel Firas Badin Florian Guisier Frank Griesinger Gaelle Rousseau-Bussac Gavitt Woodard Heiko von der Leyen Ian Anderson Johannes Kratz John Crowley Laurent Greillier Matthew Gubens Michael Mann molecular assay NSCLC Olivier Bylicki Science in Seconds Virginie Westeel Wangjian Zhong
Special Coverage
Voices
Aug 25, 2025, 13:34
Gevorg Tamamyan: Hemostasis Today - A New Era in Hemostasis and Thrombosis Reporting
Career Updates
Aug 25, 2025, 13:16
Jouliana Sadek Joins the Kyowa Kirin North America Team as Associate Director, Medical Value Outcomes Liaison
FDA Approvals
Aug 25, 2025, 13:00
FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC
Science
Aug 25, 2025, 12:37
Stephen V Liu: Chronic Kidney Disease Risk After Cisplatin Chemotherapy
Insight
Aug 25, 2025, 12:23
Catharine Young: Why We Fund Science and Specifically mRNA Research
Voices
Aug 25, 2025, 12:17
Amalya Sargsyan: Some People Don’t Just Save Lives, They Change the Way Others Do It
Voices
Aug 25, 2025, 12:13
Katy Beckermann: Privileged to Moderate World Conference On GU Cancers Panel of Amazing Colleagues
Voices
Aug 25, 2025, 11:37
Emmanuella-Faith Amoako: Turning a Moment into a Mission for Pediatric Cancer Care in Ghana
Voices
Aug 25, 2025, 11:07
Miriam Mutebi: From Lab Bench to Bedside
Opinion
Aug 25, 2025, 10:40
Udhayvir Grewal Thanks Jen Riechek for Her Leadership in ASCO EO/AYA Community of Practice
Science
Aug 25, 2025, 09:45
Myeloma Paper of the Day, August 25th, Suggested by Robert Orlowski
Voices
Aug 25, 2025, 09:35
Abdu Adem Yesufe: SPHMMC LINAC Installation Is Complete - A Milestone for Patient Care